IO Biotech, Inc. (IOBT): Price and Financial Metrics
IOBT Price/Volume Stats
| Current price | $1.60 | 52-week high | $1.73 |
| Prev. close | $1.50 | 52-week low | $0.66 |
| Day low | $1.50 | Volume | 182,028 |
| Day high | $1.60 | Avg. volume | 160,519 |
| 50-day MA | $1.07 | Dividend yield | N/A |
| 200-day MA | $1.02 | Market Cap | 105.41M |
IOBT Stock Price Chart Interactive Chart >
IO Biotech, Inc. (IOBT) Company Bio
IO Biotech, Inc., a clinical-stage biopharmaceutical company, develops disruptive immune modulating anti-cancer therapies in Denmark. The company's lead product candidate, IO102-IO103, is designed to target immunosuppressive proteins, such as Indoleamine 2,3-dehydrogenase (IDO), and programmed death ligand (PD-L1). It also develops IO112, a product candidate that contains a single Arginase 1-derived peptide designed to target T cells that recognize epitopes derived from Arginase 1 for the treatment of cancers. IO Biotech, Inc. was incorporated in 2021 and is based in Copenhagen, Denmark.
IOBT Latest News Stream
| Event/Time | News Detail | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
IOBT Price Returns
| 1-mo | 62.44% |
| 3-mo | 77.78% |
| 6-mo | 86.05% |
| 1-year | 28.00% |
| 3-year | -68.06% |
| 5-year | N/A |
| YTD | 73.91% |
| 2024 | -51.06% |
| 2023 | -18.26% |
| 2022 | -64.06% |
| 2021 | N/A |
| 2020 | N/A |